BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2010
View Archived Issues
New mechanism of action of AN-3365 linked to potent activity in Gram-negative bacterial infections
Read More
AVL-292 shows promise in models of arthritis and cancer and enters clinical development
Read More
Lipideon Biotechnology claims new cholesterol absorption inhibitors
Read More
Novartis discontinues development of albinterferon alfa-2b and Mycograb
Read More
Phase II data reported on Cevira in patients with mild cervical abnormalities
Read More
Zabofloxacin shows cardiac safety in phase I trial in healthy subjects
Read More
AS-2041835 and micafungin show synergistic antifungal activity in preclinical study
Read More
Phase II rasagiline trial in parkinsonian multiple system atrophy / News in Context
Read More
Daiichi Sankyo launches gel formulation of Loxonin in Japan
Read More
Lundbeck acquires exclusive rights to KW-6356 from Kyowa Hakko Kirin
Read More
Brain Factory gains Japanese rights to Eisai's ravuconazole prodrug
Read More
Human Genome Sciences and Novartis halt Zalbin development for HCV infection
Read More
Reviva Pharma claims new ligands of dopamine D2 receptor and serotonin receptors 5-HT1A/2A
Read More
Ambit Biosciences presents new inhibitors of JAK2 and JAK3
Read More
Pfizer describes new antagonists of calcium-sensing CaS receptor
Read More
Glenmark Pharma identifies new TRPM8 channel antagonists
Read More
FDA extends Xifaxan sNDA PDUFA goal date by 3 months
Read More
ProteoTech and Tasly collaborate on Exebryl-1 for Alzheimer's disease
Read More
Teva provides update on status of BLA for Neutroval in neutropenia
Read More
FDA approves Kapvay for use with stimulant medication for ADHD
Read More
Meda acquires erectile dysfunction therapy Muse from Vivus
Read More
Noven acquires Daytrana methylphenidate transdermal system from Shire
Read More
Enrollment complete for phase III trial of AG200-15 contraceptive patch
Read More
DSP and SanBio develop new stem cell therapy for stroke
Read More
Evotec and Shionogi form multiple-target drug discovery alliance
Read More